Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6133271 | Journal of Virological Methods | 2015 | 9 Pages |
Abstract
No effective prophylactic or therapeutic vaccine against HIV-1 in humans is currently available. This study analyzes the immunogenicity and safety of a recombinant attenuated vaccinia virus. A chimeric gene of HIV-1 multi-epitope genes containing CpG ODN and cholera toxin B subunit (CTB) was inserted into Chinese vaccinia virus Tian Tan strain (VTT) mutant strain. The recombinant virus rddVTT-CCMp24 was assessed for immunogenicity and safety in mice. Results showed that the protein CCMp24 was expressed stably in BHK-21 infected with rddVTT-CCMp24. And the recombinant virus induced the production of HIV-1 p24 specific immunoglobulin G (IgG), IL-2 and IL-4. The recombinant vaccine induced γ-interferon secretion against HIV peptides, and elicited a certain levels of immunological memory. Results indicated that the recombinant virus had certain immunogenicity to HIV-1. Additionally, the virulence of the recombinant virus was been attenuated in vivo of mice compared with wild type VTT (wtVTT), and the introduction of CTB and HIV Mp24 did not alter the infectivity and virulence of defective vaccinia virus.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Shouwen Du, Yuhang Wang, Cunxia Liu, Maopeng Wang, Yilong Zhu, Peng Tan, Dayong Ren, Xiao Li, Mingyao Tian, Ronglan Yin, Chang Li, Ningyi Jin,